Search Within

Jessica R Chapman-Lim

Formats
  1. Journal Article (4)
  2. Review (4)
  3. Meeting Abstract (2)
  4. Editorial (1)
Groups
  1. Department of Pathology and Laboratory Medicine (11)
  2. Center for Hematologic Malignancies (4)
  3. Department of Medicine (3)
  4. Hematologic Malignancies, Division of (3)
  5. Sloan Kettering Institute Postdocs (3)
  6. Bone Marrow Transplant (2)

More Groups

People
  1. Ahmet Dogan (6)
  2. Maria Stella Ritorto (3)
  3. San Yi (3)
  4. Anna Liu (2)
  5. Carlo De Oliveira Martins (2)
  6. Heather Landau (2)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (1)
  4. 2021 (3)
  5. 2020 (3)
  6. 2019 (1)

More Years

Publications
  1. Laboratory Investigation (2)
  2. American Journal of Surgical Pathology (1)
  3. Amyloid (1)
  4. Best Practice and Research: Clinical Haematology (1)
  5. Clinical Cancer Research (1)
  6. Clinical Chemistry (1)

More Publications

Publishers
  1. Nature Publishing Group (2)
  2. Amer Soc Biochemistry Molecular Biology Inc (1)
  3. American Association for Cancer Research (1)
  4. American Association for Clinical Chemistry (1)
  5. Elsevier Inc. (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An investigation of mass spectrometry-based proteomics for the detection and monitoring of high-grade urothelial carcinoma using voided urine specimens
    Meeting Abstract

    Walland, A.; Ng, D.; Feratovic, R.; Lin, O.; Chapman, J.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Mass spectrometry–based proteomics for the masses: Peptide and protein identification in the Hunt laboratory during the 2000's
    Review

    Chapman, J. R.
    Molecular & Cellular Proteomics (2024)

    Fulltext@MSK | Save
  • Tissue mass spectrometry: How solid is our future?
    Editorial

    Unsihuay, D.; Phipps, W. S.; Paulovich, A. G.; Chapman, J. R.; Ducret, A.; Eberlin, L. S.; Spraggins, J. M.; Goodwin, R. J. A.
    Clinical Chemistry (2023)

    Fulltext@MSK | Save
  • Minimal residual disease in myeloma: Application for clinical care and new drug registration
    Review

    Anderson, K. C.; Auclair, D.; Adam, S. J.; Agarwal, A.; Anderson, M.; Avet-Loiseau, H.; Bustoros, M.; Chapman, J.; Connors, D. E.; Dash, A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Localized peritumoral AL amyloidosis associated with mantle cell lymphoma with plasmacytic differentiation
    Journal Article

    Yabe, M.; Ozkaya, N.; de Jong, D.; Aypar, U.; Ritorto, M. S.; Barbé, E.; Miedema, I. H. C.; Sen, F.; Chapman, J. R.; Landau, H. J.; more...
    American Journal of Surgical Pathology (2021)

    Fulltext@MSK | Save
  • Proteomic analysis shows that the main constituent of subepidermal localised cutaneous amyloidosis is not galectin-7
    Journal Article

    Chapman, J. R.; Liu, A.; Yi, S. S.; Hernandez, E.; Ritorto, M. S.; Jungbluth, A. A.; Pulitzer, M.; Dogan, A.
    Amyloid (2021)

    Fulltext@MSK | Save
  • Mass spectrometry-based method targeting Ig variable regions for assessment of minimal residual disease in multiple myeloma
    Journal Article

    Martins, C. O.; Huet, S.; Yi, S. S.; Ritorto, M. S.; Landgren, O.; Dogan, A.; Chapman, J. R.
    Journal of Molecular Diagnostics (2020)

    Fulltext@MSK | Save
  • Mammary amyloidosis: An uncommon entity that may present as mammographic microcalcifications
    Meeting Abstract

    Cheng, E.; Chapman-Lim, J.; Liu, A.; Dogan, A.; Argani, P.; D'Alfonso, T.; Hoda, S.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Tracking of low disease burden in multiple myeloma: Using mass spectrometry assays in peripheral blood
    Review

    Chapman, J. R.; Thoren, K. L.
    Best Practice and Research: Clinical Haematology (2020)

    Fulltext@MSK | Save
  • Fibrinogen alpha amyloidosis: Insights from proteomics
    Review

    Chapman, J.; Dogan, A.
    Expert Review of Proteomics (2019)

    Fulltext@MSK | Save